Article result template
I'm a little template short and blank. I link to void and keep hidden out.
2024-11-19T10:00:23+0000
CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.
I'm a little template short and blank. I link to void and keep hidden out.
2024-11-19T10:00:23+0000
ResMed reports a significant revenue rise of 9% to $1.22 billion USD in the June quarter, highlighting its strong market position despite concerns over weight loss drugs impacting product demand.
2024-08-05T08:13:42+0100
After an initial negative reaction to the weight-loss drug thematic, ResMed says the trend will boost demand for its products. However, with alcohol consumption amongst GLP-1 patients waning, beverage companies could suffer.
2024-05-08T01:11:22+0100
Explore how GLP-1 drugs like Wegovy, Ozempic, and Mounjaro are reshaping the obesity treatment landscape, boosting market valuations for Novo Nordisk and Eli Lilly, and influencing sectors from healthcare to consumer goods.
2023-11-15T00:54:27+0000